Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Transplant with Reduced-Intensity Conditioning for Hematological Malignancies
NCT00723099Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 2008
- Primary completion
- Jul 2018
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), chronic myelogenous leukemia (CML), myelodysplastic syndrome (MDS), sponsored by Fred Hutchinson Cancer Center. Started Jun 2008; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)non-Hodgkin lymphoma (NHL)chronic myelogenous leukemia (CML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00723099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723099.